» Articles » PMID: 39886435

Total Syntheses of Cyclohelminthol I-IV Reveal a New Cysteine-selective Covalent Reactive Group

Overview
Journal Chem Sci
Date 2025 Jan 31
PMID 39886435
Authors
Affiliations
Soon will be listed here.
Abstract

Biocompatible covalent reactive groups (CRGs) play pivotal roles in several areas of chemical biology and the life sciences, including targeted covalent inhibitor design and preparation of advanced biologic drugs, such as antibody-drug conjugates. In this study, we present the discovery that the small, chlorinated polyketide natural product cyclohelminthiol II (CHM-II) acts as a new type of cysteine/thiol-targeting CRG incorporating both reversible and irreversible reactivity. We devise the first syntheses of four simple cyclohelminthols, (±)-cyclohelminthol I-IV, with selective chlorinations (at C and C) and a Ni-catalyzed reductive cross coupling between an enone, a vinyl bromide and triethylsilyl chloride as the key steps. Unbiased biological profiling (cell painting) was used to discover a putative covalent mechanism for CHM-II in cells with subsequent validation experiments demonstrating mechanistic similarity to dimethyl fumarate (DMF) - a known (covalent) drug used in the treatment of multiple sclerosis. Focused biochemical experiments revealed divergent thiol-reactivity inherent to the CHM-II scaffold and through further chemical derivatization of CHM-II we applied activity-based protein profiling (ABPP)-workflows to show exclusive cysteine-labelling in cell lysate. Overall, this study provides both efficient synthetic access to the CHM-II chemotype - and neighboring chemical space - and proof-of-concept for several potential applications of this new privileged CRG-class within covalent chemical biology.

References
1.
Ryter S . Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants (Basel). 2022; 11(3). PMC: 8944973. DOI: 10.3390/antiox11030555. View

2.
Dubiella C, Pinch B, Koikawa K, Zaidman D, Poon E, Manz T . Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nat Chem Biol. 2021; 17(9):954-963. PMC: 9119696. DOI: 10.1038/s41589-021-00786-7. View

3.
Blewett M, Xie J, Zaro B, Backus K, Altman A, Teijaro J . Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. Sci Signal. 2016; 9(445):rs10. PMC: 5068918. DOI: 10.1126/scisignal.aaf7694. View

4.
Walsh S, Omarjee S, Galloway W, Kwan T, Sore H, Parker J . A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody-drug conjugates. Chem Sci. 2019; 10(3):694-700. PMC: 6349026. DOI: 10.1039/c8sc04645j. View

5.
Wormer G, Villadsen N, Norby P, Poulsen T . Concise Asymmetric Syntheses of Streptazone A and Abikoviromycin*. Angew Chem Int Ed Engl. 2021; 60(19):10521-10525. DOI: 10.1002/anie.202101439. View